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Abstract
The discovery of functional molecules is an expensive and time-consuming pro-
cess, exemplified by the rising costs of small molecule therapeutic discovery. One class
of techniques of growing interest for early-stage drug discovery is de novo molecu-
lar generation and optimization, catalyzed by the development of new deep learning
approaches.1 These techniques can suggest novel molecular structures intended to max-
imize a multi-objective function, e.g., suitability as a therapeutic against a particular
target,2 without relying on brute-force exploration of a chemical space.3 However, the
utility of these approaches is stymied by ignorance of synthesizability. To highlight
the severity of this issue, we use a data-driven computer-aided synthesis planning pro-
gram4 to quantify how often molecules proposed by state-of-the-art generative models
cannot be readily synthesized. Our analysis demonstrates that there are several tasks
for which these models generate unrealistic molecular structures despite performing
well on popular quantitative benchmarks. Synthetic complexity heuristics can success-
fully bias generation toward synthetically-tractable chemical space, although doing so
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necessarily detracts from the primary objective. This analysis suggests that to improve
the utility of these models in real discovery workflows, new algorithm development is
warranted.
Introduction
Molecular design is one of the most fundamental challenges in chemical science and en-
gineering. This task is to identify one or more molecules with a specific set of properties of
interest, such as binding affinity and drug-likeness for drug design. High-throughput virtual
screening (VS) is one widely used strategy to coarsely optimize a molecular structure using
a discretized subspace of the whole chemical space.5 In VS, we evaluate enumerated can-
didate molecules in terms of their predicted properties of interest and ranked for follow-up
experimental validation. However, because we rarely know a priori where the ideal molecule
will be within the massive design space of chemical space, there is a trend toward using
exceedingly large virtual libraries to increase the likelihood that we will find promising can-
didates. Modern virtual libraries may comprise hundreds of millions or billions of candidate
molecules,3 often generated through combinatorial enumeration of commercially-available
building block compounds. Even billions of compounds, however, represent a tiny fraction
of theoretically-possible, pharmacologically-relevant small molecules, often cited as exceed-
ing 1060 structures.6 Brute-force virtual screening screening over a chemical space of this size
is clearly computationally intractable.
Recent developments in computer aided drug design (CADD) techniques, especially in
de novo molecular generation and optimization methods, raise the hope of removing this
bottleneck.1 Generative algorithms are a class of methods that propose molecular structures
in a manner that can be tailored toward a specific objective. There is a long history of gener-
ative models in chemistry, many based on genetic algorithms7 and the iterative construction
of molecules from molecular fragments.8 In the past decade, following on the advent of Vari-
ational Auto-Encoders (VAEs)9 and Generative Adversarial Networks (GANs),10 there has
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been a flood of new deep learning (DL) methods for this task.11 Many of these methods learn
a mapping from a continuous lower-dimensional real number space to a discrete chemical
space. Jointly trained with a structure-property regression, one can obtain novel chemical
structures conditioned on desired properties. More usefully, combining generative models
with Bayesian optimization (BO), or directly using a heuristic optimization algorithm (e.g.,
a genetic algorithm (GA) or tree search (TS)), we can bias candidate generation toward the
functionality we desire. Deep generative models are trained on a finite set of molecules to
learn an underlying distribution of chemical space, where interpolation and extrapolation
produce novel chemical structures. Enumerating every candidate molecule is thus unnec-
essary, and applying these models requires linear computational cost to generate multiple
molecular structures once trained. Further, the generative algorithms can explore chemical
space beyond the limited beginning pool and provide novel chemical structures with prefer-
ential intellectual property (IP) positions, whereas molecules in VS are often pre-existing.
In recent years, generative models have been applied to various chemical discovery problems
and have shown promise as a useful tool for the problem of molecular design.2
However, a practical problem that obstructs the usefulness of generative algorithms is
that proposed molecular structures may be challenging or infeasible to synthesize. In any
realistic discovery scenario, we will need to validate whether a proposed molecule has the
property profile we expect; even if our computational models are infallible, we will need
to manufacture the molecule in order to apply it (e.g., as a therapeutic, as a catalyst, as a
component of a device). Libraries for virtual screening can be constructed from commercially-
available databases. They are often enumerated using well-characterized reaction templates
to try to ensure that enumerated molecules are readily synthesizable. Lyu et al. report an
86% successfully synthesis rate among 51 top-ranking molecules from a library comprising
99 million structures, consistent with the claims of many chemical vendors.3
The situation is quite different in de novo molecular design, especially when using deep
generative methods. We expect (and want) these models to explore molecular structures
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beyond the ones they have been trained on, so they may propose nonsensical structures
that are unreasonable for pharmaceutical purposes. There have been few studies explicitly
examining this problem, but some anecdotal evidence suggests that compounds are not
easily synthesizable—many structures reported in papers indeed appear absurd. Bjerrum
and Threlfall examined 21 molecules proposed by their recurrent neural network (RNN)
model with Wiley’s ChemPlanner and found a number of possible selectivity issues in the
proposed syntheses, indicating synthetic difficulty.12 Sumita et al. filter generated molecules
by requiring that they be previously reported with at least one synthetic route in SciFinder,
which removes these models’ ability to propose novel chemical structures.13 Zhavoronkov
et al. select only 6 molecules from 40 candidates structures based on synthetic accessibility,
even after filtering an initial list of 30,000 structures generated by a deep learning model.2
Current procedures for quantifying synthesizability are based on (1) structure complex-
ity and similarity or (2) synthetic pathways. The structure-based approach usually involves
constructing a heuristic definition based on domain expertise or chemical substructure di-
versity14,15 or designing a model that can be fit to expert scores16–18 or reaction data.19,20
This kind of method is widely used due to its ease of implementation and low computational
cost. However, two similar structures with a single functional group transposition can re-
quire substantially different synthetic routes (e.g., due to the selectivity of chemical reactions
or availability of specific building blocks), which makes it challenging to fit a good proxy
score (see Figure S1 and S2 for one example). The most convincing metric might be a direct
scoring from a group of experts on synthetic, medicinal chemistry, which has been used as a
ground truth to train models against.16–19 To have a group of experts that large enough to
reach a non-biased and stable value is labor-intensive, hard to replicate, and not scalable.21
The second, more nuanced approach to measuring synthesizability is to explicitly plan
a synthetic pathway and assess its likelihood of experimental validity. Synthetic pathway-
based approaches can incorporate more thorough information about starting materials and
chemical reactions, which enable them to overcome the shortcomings of the structure-based
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analysis. In this approach, a computer-aided synthesis planning (CASP) program22 can be
used to perform the retrosynthetic analysis. Using an explicit CASP tool is capable not only
of capturing the high “non-linearity” of synthesizability with respect to chemical structure,
but of recommending actionable synthetic pathways. We see this as a form of interpretability
to verify why the molecule is believed to be synthesizable, with which building blocks, and
in how many steps. Only a handful of studies have used a retrosynthetic planning tool to
analyze synthesizability.12,23–25 Its practical application in molecular design is not widespread
yet. Therefore, here, we analyze synthesizability of compounds proposed through generative
algorithms using our open-source computer-aided retrosynthesis analysis tool, ASKCOS.4
We divide our analysis of the synthesizability of molecules generated by de novo genera-
tive algorithms into evaluations of distribution learning and goal-directed generation tasks–
unoptimized and optimized molecules, respectively. Distribution learning models are meant
to interpolate within a chemical space comprised a training set of molecules and generate
new molecules with similar properties. Goal-directed generation instead tries to generate
new molecules that maximize a black-box scoring function. There are an increasing num-
ber of algorithms of these two categories proposed in recent years and a small number of
studies that benchmark these algorithms in terms of their ability to generate novel, optimal
molecules.26,27
We categorize the approaches one might take to ensure that computationally designed
molecules are able to be synthesized in Figure 1. These represent combinations of (i) a
database of known or enumerated compounds, (ii) an evaluator, which estimates the prop-
erties we are trying to optimize, (iii) a generator function, which can propose new candidate
molecules, (iv) a synthesizability oracle that determines whether it is straightforward to syn-
thesize a given molecule, and/or (v) a heuristic synthesizability estimator that provides a
computationally-inexpensive scalar measure of synthesizability. In this study, we focus on
three major approaches to solving the synthesizability problem: post hoc filtering (Figure 1c),
imposing a priori differences in training sets (Figure 1d), and heuristic biasing (Figure 1e).
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Figure 1: Schematic representation of approaches to address the challenge of synthesizability
in molecular optimization: (a) virtual screening can use a filtered database of candidates to
ensure that they are all synthetically accessible; (b) standard molecular generation focuses
on evaluation of properties without regard for synthesizability; (c) a post hoc filter narrows
down proposed candidates as a separate step from generation; (d) biasing by training set
aims to improve synthesizability by training generative models on synthetically-accessible
compounds; (e) biasing by heuristics uses simple scalar proxies for synthesizability as part
of the objective function; (f) biasing by a CASP oracle runs a full retrosynthetic expansion
for proposed molecules to modify the reward function in a reinforcement learning setting;
and (g) explicit constraints attempt to restrict chemical space to what is accessible using
buyable building blocks and known synthetic transformations.
Results
Synthesizability of common databases according to ASKCOS
We first validate that the information returned by ASKCOS is usefully correlated with
synthesizability by analyzing molecules from several standard compound libraries: MOSES,26
ChEMBL,28 ZINC,29 Sheridan et al.,17 and GDB1730 (see Methods for detailed descriptions
of each data set and the settings used for retrosynthetic analysis, including the evaluation
of commercial availability of building blocks). Figure 2a shows the predicted number of
synthetic steps required to produce a random set of 3000 molecules from each data set. The
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MOSES data set has the highest rate of perceived synthesizability at 89.8%, consistent with
its focus on small lead molecules and exclusion of compounds with “structural alerts”. Its
parent set, ZINC, has a lower synthesizability rate of 60.8%. The ChEMBL data set has
a higher rate of 68.3%; although it contains larger and more complex structures than does
ZINC, many have been synthesized previously; among those that cannot be synthesized are
natural products that were extracted, not synthesized, and tested for their biological activ-
ity. ChEMBL also contains several directly purchasable compounds, second only to Sheridan
et al.’s data set of 1730 compounds. Unsurprisingly, the exhaustively enumerated data set,
GDB17, has the lowest rate of synthesizability at only 3.5%. We also find that the predicted
number of reaction steps is correlated with expert-provided scores (Figure S14). From these
trends and the high success rate of the MOSES database, we conclude that ASKCOS’s ret-
rosynthetic analyses are largely consistent with our expectations of synthesizability and it is
appropriate to use its predictions to benchmark the evaluation of molecular generation.
Agreement between synthesizability heuristics and ASKCOS
We next evaluate the agreement between several heuristic synthesizability scores (length
of SMILES, SA Score,31 and SCScore20) and the results of ASKCOS. Because retrosyn-
thetic analysis can be time consuming (tens to hundreds of CPU-seconds), we would prefer
to bias generation by heuristics rather than by a CASP oracle (cf. Figure 1). Figure 2c-e
show the trend of synthesizability of structures in different range of SA Score, SCScore, and
SMILES string length. None of them can distinguish the synthesizable and unsynthesizable
compounds perfectly, but all exhibit a decreasing trend as the heuristic score increase. The
trend is clearest for the SA Score, followed by the SMILES length and then the SCScore.
This ordering is quantified in Figure S3, which shows the area under the receiver operating
characteristic as if these heuristics were being used for binary classification. The AUC val-
ues for the three methods in this order are 0.87, 0.69, and 0.61. The slight shoulder around
5.5-6.0 is the contribution from the structurally complex but commercially available com-
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Figure 2: The synthesizability analysis of common data sets, distribution learning, and
popular heuristics. (a) the number of synthetic steps required to produce random sampled
structures from each data set; (b) the number of synthetic steps required to produce molecules
generated by distribution learning algorithms, trained on either MOSES or ChEMBL; (c-e)
the fraction of synthesizable compounds from each dataset binned by heuristic score and the
number of molecules scored within each bin (excluding GDB).
pounds, highlighting the difference between synthetic complexity and structural complexity
as discussed in ref. 20.
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Synthesizability of unoptimized generated molecules
As alluded to above, distribution learning methods are capable of generating “unopti-
mized” molecules that share properties (in aggregate) with the database used for training.
Here, we evaluate methods implemented in the MOSES26 benchmarking set, which cover di-
verse approaches to the molecular generation problem: a SMILES long short-term memory
(LSTM) model, a variational auto-encoder (VAE), and an adversarial auto-encoder (AAE)
(see Methods). There are more deep learning approaches for molecular generation and op-
timization than can be compared here,11 so we focus on these top-performing classes of
approaches. In this task, we can use post hoc filtering or training set biasing by separately
training distribution learning models on ChEMBL (less synthesizable) and MOSES (more
synthesizable).
Figure 2b shows the fraction of synthesizable molecules from 300 generated by each
distribution learning method trained on the ChEMBL and MOSES. We observe that the
fraction of synthesizable molecules are comparable to that of the training set, while no
method improves synthesizability relative to its training set. The stark difference between
results using MOSES and ChEMBL suggests that a priori biasing by training on a “more
synthesizable” data set is a viable approach for distribution learning algorithms. There is
no one method particularly superior than others. The high fraction of synthesizable results
further suggests that post hoc filtering is not necessarily a bad approach (i.e., relatively few
generated molecules would fail a check for synthesizability). Note these results pertain only
to the synthesizability of generated results and do not consider previously evaluated metrics
of novelty, uniqueness and diversity as do Polykovskiy et al.’s analyses.26
Synthesizability of optimized generated molecules
Our next analyses focus on goal-directed benchmarks, which reflect the actual use-case
for generative models. Here, we re-evaluate the methods and objective functions evaluated
by Brown et al.’s Guacamol27 in terms of their synthesizability. As detailed in the Methods,
9
Figure 3: Dependence of goal-directed optimization performance on heuristic biasing by the
SA Score using ChEMBL as the training database. Each row represents result from one
generative method; each column represents one objective function. In each plot, the green
solid line represents the change of fraction of synthesizable compounds in the top-100 with
the green dashed line as a reference for the synthesizability of the training set (ChEMBL).
Red solid lines represent the change in the objective function value of the top synthesizable
molecule, while the dashed red line represents the change in objective function value of the
top molecule, regardless of its synthesizability. Plots without a solid red line indicates that
no synthesizable structure was obtained in the top 100 molecules; dashed red lines may be
occluded by solid red lines.
this includes three generative algorithms (SMILES LSTM, SMILES GA, and Graph GA)
and 14 multi-property objective functions (MPOs) that convert a molecular structure to a
scalar fitness score. As a baseline method, we include a virtual screening approach, “Best
from Data”, where all candidates from either ChEMBL or MOSES are evaluated to identify
the top performers. In addition to post hoc filtering and training set biasing, we can also bias
generation by modifying the objective function with a heuristic synthesizability score. We
multiply the original objective functions (normalized between 0 and 1) with a quantitative
synthesizability metric (SA Score or SCScore, also normalized between 0 and 1). More
details can be found in Methods section.
We evaluate the effects of heuristic biasing both in terms of the synthesizability of sug-
gested molecules and in terms of the primary objective function value. Figure 3 shows
how these metrics change when biasing with SA Score, initially trained on ChEMBL (Fig-
ure S5 shows additional results using the SCScore/ChEMBL, SA Score/MOSES, and SC-
Score/MOSES). Compared to the synthesizability of starting set (the green dashed lines), we
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a  SMILES GA on Osimertinib MPO
d  Graph GA on Deco Hop
c  Graph GA on Valsartan SMARTS
b  Graph GA on Sitagliptin MPO
Unbiased
Top unsynthesizable: 0.881
None synthesizable in top 100
Biased by SA_Score
Top synthesizable: 0.837 (-0.044)
Biased by SCScore
Top synthesizable: 0.793 (-0.088)
Unbiased
Top unsynthesizable: 0.843
None synthesizable in top 100
Biased by SA_Score
Top synthesizable: 0.602 (-0.241)
Biased by SCScore
Top synthesizable: 0.697 (-0.146)
Unbiased
Top unsynthesizable: 0.986
Unbiased
Top synthesizable: 0.699 (-0.287)
Biased by SA_Score
Top synthesizable: 0.963 (-0.023)
Biased by SCScore
Top synthesizable: 0.596 (-0.390)
Unbiased
Top unsynthesizable: 0.938
Unbiased
Top synthesizable: 0.938 (-0.000)
Biased by SA_Score
Top synthesizable: 0.991 (+0.053)
Biased by SCScore
Top synthesizable: 0.892 (-0.046)
Figure 4: Examples of molecules from goal-directed optimization that were improved by
heuristic biasing. Scores shown are the objective function values that have been normalized
to the interval [0, 1]. (a,b) cases where no synthesizable compounds were found in the
top 100 suggestions without biasing, but at least one was found with either SA Score or
SCScore biasing. (c,d) cases where the top structure found without biasing was perceived
as unsynthesizable and the use of heuristic biasing improved the objective function value of
the top synthesizable structure.
can see the synthesizability varies between different methods and objectives. Indeed, the to-
tal fraction of synthesizable compounds in all methods for “hard” objectives without biasing
is 30.2% with ChEMBL and 32.7% with MOSES (see Figure S6 for more details), excluding
the direct sampling from data set. Compared to distribution learning, the goal-directed gen-
eration methods are less sensitive to the starting set of molecular compounds. For several
tasks (Figure S6), very few or no compounds in the top 100 are synthesizable in the absence
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of heuristic biasing, particularly when using the genetic algorithms, illustrating the risk of
relying on a post hoc filtering strategy. Examples in Figure 4ab illustrate cases where no
molecule in the top 100 is synthesizable and heuristic biasing is required to generate even
a single feasible candidate. The compounds remaining after filtering for synthesizability, if
any, may have low objective function values.
Most cases in Figure 3 show that the synthesizability of the top 100 compounds after
biasing is quite high, often exceeding the rate for ChEMBL. Generally speaking, the SA Score
performs better than SCScore (Figure S5): the overall synthesizability for hard objectives was
improved from 30.2% to 80.2% or 55.4% when biasing by SA Score or SCScore, respectively,
originally trained on ChEMBL (Table 1). This successful result validates the approach shown
in Figure 1e, but the increased synthesizability comes at the expense of the objective function
value of the top candidate. For some tasks decreases by over 0.2–a significant difference for
these benchmark tasks. However, we note that the value of an in silico objective function is
completely inconsequential if the molecule cannot be made and experimentally tested.
Table 1: Fraction of synthesizable compounds in the top-100 candidates across all goal-
directed optimization tasks and all methods, demonstrating successful heuristic biasing.
Training database Task difficulty Unbiased Biased by SA Score Biased by SCScore
ChEMBL
trivial 60.1% 91.0% 77.9%
hard 30.2% 80.2% 55.4%
MOSES
trivial 63.5% 92.2% 78.8%
hard 32.7% 77.2% 58.0%
A fairer comparison can be made between the objective function values of the top syn-
thesizable candidates, i.e., after post hoc filtering. Figure 4cd shows two examples where the
objective of the top-1 candidate decreased, but the value of the top-1 synthesizable candidate
increased. That this is observed in some cases (also see Figure S13) suggests a practical work-
flow for molecular optimization: if only a few synthesizable candidates (1-10) are desired,
first optimize without biasing and filter unsynthesizable suggestions; if the top synthesizable
candidates are worse than the top unsynthesizable candidates, repeat the optimization while
biasing with the SA score.
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Discussion of other approaches
As described in Figure 1, there are more ways to improve synthesizability of de novo
molecular generation algorithms. One promising approach is to bias the generation using
a full CASP tool to evaluate synthesizability, instead of a proxy score (Figure 1f). The
advantages are already described above; the disadvantage is the computational expense.
While ASKCOS finds pathways in a few seconds for some molecules, we spend up to one
minute evaluating each molecule to reduce the number of false negatives.
Benchmarking for molecular optimization, in addition to neglecting synthesizability, has
largely neglected the number of objective function calls and computational expense. When
using genetic algorithms for molecular optimization, we would first select high scoring synthe-
sizable compounds as the initial set to propagate from a pool of up to millions of structures
(∼ 106) and then score, at each of hundreds of iterations (∼ 103), hundreds of child com-
pounds (∼ 103). In total, we would require millions or at least hundreds of thousands of
calls to the CASP oracle. Reinforcement-learning-based optimization methods that out-
perform Bayesian optimization when using VAEs require one oracle call per iteration, but
require hundreds of thousands or millions of iterations (e.g., MolDQN reports the use of
200k function calls32). One study by Korovina et al., who propose a method described in
the next paragraph, highlight several existing methods that all require ≥ 5 thousand evalu-
ations for a single task compared to their 100. Based on the machine learning community’s
broader interest in improving the sample efficiency of reinforcement learning algorithms34
(thus fewer times calling the oracle) and CASP tools becoming faster, the use of an explicit
retrosynthetic planner during optimization may become a computationally viable strategy.
The final approach (Figure 1g) is to embed synthesizability constraints in the generation
algorithm itself, i.e., constrain the search space to molecules that can be produced from
available building blocks. As early as 2003, Vinkers et al. describe the iterative optimiza-
tion of molecular structure by selecting building blocks to react with a growing molecular
structure.35 More recently, Bradshaw et al. 36 propose a model called MoleculeChef that gen-
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erates a bag of reactants and uses a forward reaction prediction software to obtain the final
products. Korovina et al.’s ChemBO similarly treats molecular generation as a random walk
on a directed (synthetic) graph where each node is a molecule, and the parents of this node
are the reagents that produce the child molecule when combined.33 These techniques are
philosophically aligned with our use of retrosynthetic analysis to evaluate synthesizability–
both try to use our collective knowledge of chemical reactivity to dictate what reactions are
possible–but operate in the forward synthetic direction. This makes them subject to the
same caveats that any CASP tool is subject to: their validity is entirely dependent on the
accuracy of their forward reaction prediction engine, which can use either hand-coded rules
or algorithmically-inferred rules. The greater the number of synthetic steps we allow, the
lower the chances that each reaction will proceed as predicted. As this is essentially how
virtual libraries are constructed, we would expect a similar rate of success (anecdotally, 85%
successful delivery of compounds from a library enumerated with a single synthetic step).
Nevertheless, as the search space is directly constrained by these rules, they may enable a
more efficient exploration of chemical space. We expect such algorithms to rapidly grow in
popularity as the accuracy of reaction prediction tools improves.37,38
Conclusion
In this paper, we describe an analysis of the synthesizability of de novo generative algo-
rithms. We first examined common chemical compound libraries and used ASKCOS to eval-
uate their synthesizability. We next evaluated molecules proposed by distribution learning
and goal-directed generation methods, with and without biasing by heuristic synthesizability
metrics. Distribution learning methods, provided they can learn the chemical distribution
of the training set well, seem to generate molecules that are synthesizable with a similar
frequency to their training set. Goal-directed generation methods have a significant risk of
proposing unsynthesizable structures as their top suggestions, particularly using the SMILES
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GA or Graph GA methods, but occasionally there may be enough high-performing, synthe-
sizable molecules in the top 100 that post hoc filtering (Figure 1c) is a viable strategy. In
other cases, the proposed molecules are so absurd that one immediately recognizes why
benchmarking these methods solely in terms of their objective function value is insufficient
(e.g., Figure S10 and S11). Biasing generation by training set synthesizability (Figure 1d)
works for distribution learning, but does not have a noticeable effect on goal-directed opti-
mization tasks. For some tasks, modifying the objective function with the SA Score leads
to candidates that outperform those obtained through post hoc filtering (Figure 4cd and
Figure S13). This heuristic biasing (Figure 1e) almost always improves the synthesizability
of generated candidates, but necessarily detracts from the main objective function.
We acknowledge that the identification of a synthetic pathway by ASKCOS is not a
necessary or sufficient condition for synthesizability, nor would the generation of molecular
candidates through forward synthesis prediction be a guarantee that those reactions would
work experimentally. CASP tools for retrosynthesis and forward synthesis are imperfect.
They do not capture our entire knowledge of chemical reactivity and may occasionally pro-
duce overly optimistic suggestions (e.g., with respect to selectivity). Further, the ability
of CASP programs to find pathways is sensitive to the precise database of chemicals con-
sidered buyable and the settings one chooses for the retrosynthetic expansion. Even with
an imperfect CASP tool like ASKCOS, however, we can obtain a meaningful analysis of
synthesizability of generated molecules.
Generative models have a tremendous potential to accelerate molecular discovery. As we
improve their ability to propose synthesizable molecules–whether by improving CASP tools
for post hoc filtering, developing new heuristics for synthesizability, efficiently sampling a
CASP oracle to bias generation with reinforcement learning, or designing new algorithms
explicitly constrained by predictions of chemical reactivity–their utility and relevance to
practical discovery projects will only increase.
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Methods
ASKCOS
ASKCOS is an open-source software framework that integrates efforts to generalize
known chemistry to new substrates by learning to apply retrosynthetic transformations,
to identify suitable reaction conditions, and to evaluate whether reactions are likely to
be successful when attempted experimentally.4,39 Data-driven models within ASKCOS are
trained on millions of reactions from the U.S. Patent and Trademark Office (USPTO) and
Reaxys databases. The core retrosynthetic capabilities rely on the recursive application of
algorithmically-extracted reaction templates encoded as SMARTS patterns. Expansion is
parallelized using an upper confidence bound tree search as detailed in the original publi-
cation. Importantly, ASKCOS has both programmatic and graphical interfaces to enable
thousands of compounds to be processed without human intervention. The program makes
extensive use of RDKit.40
While the program offers flexible stopping criteria, we require starting materials to be
commercially available according to a 2018 database of molecules from eMolecules or Sigma
Aldrich with prices no greater than $100 per gram; the full list is available in the ASKCOS
codebase. This is a very strict price limit in the context of drug discovery, so it warrants
two additional comments. First, one could consider most molecules to be “commercially
available”, in that some supplier or contract research organization will agree to produce them
at some cost given sufficient lead time. Second, it is straightforward to modify the database
of molecules considered commercially available depending on each user’s price tolerance and
available chemical inventory.
To determine whether a molecule is “synthesizable”, we run a retrosynthetic expansion
using ASKCOS with the following expansion settings: the maximum search depth–longest
linear sequence–is 9, the maximum branching ratio–number of unique precursors to consider
at each disconnection–is 25, the maximum wall time of expansion is 60 seconds, the maximum
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cumulative probability for target is 0.999, the maximum number of templates to apply is
1000, the maximum price for starting materials is $100/g as described above, the minimum
plausibility of reactions–evaluated by a binary classifier as a “sanity check”–is 0.1. We
terminate the search as soon as a pathway is found, rather than continuing to search for a
more optimal (e.g., shorter, cheaper) pathway. All retrosynthetic analyses were carried out
in an ASKCOS server on a debian virtual machine running on Google Cloud with 8 cores,
52 GB memory, and no other background tasks.
Compound databases
• MOSES26 is an open database included in the MOSES benchmarking platform that
evaluates distribution learning algorithms for drug discovery. The database of 1.94
million structures represents a subset of the 4.6 million in the ZINC Clean Leads
collection with molar masses of 250-350 g/mol, fewer than 8 rotatable bonds, and a
maximum XLogP of 3.5. Polykovskiy et al. filtered out molecules containing charged
atoms, atoms besides C, N, S, O, F, Cl, Br, and H, cycles longer than 8 atoms, and
molecules containing “structural alerts” from medicinal chemistry filters and PAINS
filters.
• ChEMBL28 is a regularly-updated, open access database containing a large number
of biologically-relevant compounds and associated assays (e.g., binding and ADMET).
In our experiments, we use ChEMBL release 24, which contains 15.2 million activity
measurements for 1.8 million compounds.
• ZINC41 is an open database of commercially-available (not in-stock) compounds for
virtual screening. ZINC contains over 230 million purchasable compounds in ready-
to-dock, 3D formats. We sampled molecules from ZINC-250k, which is a widely used
subset of ZINC1241 from Go´mez-Bombarelli et al..42
• Sheridan et al. 17 refers to a set of 1730 unique and parseable compounds taken from
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the 2575 unique molecules released by Merck in their paper exploring a crowdsourced
definition of molecular complexity. These molecules were drawn from various public
and Merck-internal sources as described in the original publication.
• GDB1730 is an open database containing 166.4 billion enumerated molecules with
up to 17 heavy atoms of C, N, O, S and halogens. The enumeration started from
mathematical graphs to form skeletons, aiming to cover size ranges containing many
drugs and typical for lead compounds. We are sampling from its “Lead-like Set” of 800
thousand compounds with molar masses of 100-350 g/mol, CLogP of 1-3, and without
3- or 4-membered rings.
Molecular generation algorithms
• Random sampler is a baseline approach to molecular generation and optimization that
randomly samples molecules (with replacement) from a “training set” of known com-
pounds.
• Best from data represents the virtual screening approach to molecular optimization,
where all molecules from a “training set” of known compounds are evaluated to identify
the ones with the highest scores.
• LSTM 43 refers to a Long-Short Term Memory44 neural network that is widely used
in natural language processing. The model is trained in an auto-regressive way to
predict the next character of a simplified molecular-input line-entry (SMILES) string.
It can be iteratively fine-tuned to optimize molecules toward a specific objective using
a hill-climbing algorithm. We evaluated the implementation from ref. 27.
• VAE 42 refers to a variational autoencoder architecture that learns to construct a bidi-
rectional mapping between SMILES represented chemical space and a finite-dimensional
continuous latent space. The architecture is devised to learn a probabilistic generative
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model as well as its posterior, respectively known as decoder and encoder. The two
parts are trained simultaneously by maximizing the evidence lower bound (ELBO) of
the marginal likelihood, ELBO(φ, θ) = Eqφ(z|x)[log pθ(x|z)]−KL(qφ(z|x)||p(z)), where
φ and θ are differential parameters and KL is the Kullback–Leibler (KL) divergence.
We evaluated the implementation from ref. 26.
• AAE 45 is another approach to train a SMILES-based encoder-decoder architecture.
Instead of KL regularization, AAE is trained with an adversarial learning regularization
that matches the posterior distribution to a prior distribution. We evaluated the
implementation from ref. 26.
• SMILES GA46 is a population-based grammar evolution algorithm. We evaluated
Yoshikawa et al.’s model that adopted a “chromosome” with context-free grammar of
SMILES string so that crossover and mutation happens at the level of SMILES tokens.
Each “chromosome” can be decoded to a SMILES string and checked validity using .
We evaluated the implementation from ref. 27.
• Graph GA47 is another genetic algorithm that represents molecules as graphs, rather
than relying on SMILES strings. The crossovers and mutations are performed by
altering a molecular graph directly, i.e., exchanging substructures and hand-written
substitution rules for mutation. We evaluated the implementation from ref. 27.
Objective functions for optimization
The suite of objective functions we use for goal-directed optimization were taken from
Brown et al.’s benchmarking function sets.27 Evaluation is divided into “trivial” tasks and
“hard” tasks following the language of the original work. The trivial tasks are named as such
because almost all molecular optimization methods can perform exceedingly well on them
(thus they are not suitable for the assessment of generative models), whereas the hard tasks
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show greater variation as a function of the method used. However, all of these objective
functions are relatively simple heuristic functions of molecular structure.
The trivial objectives we use include quantitative estimate of drug-likeness (QED);48 a
central nervous system (CNS) MPO;49 isomer of C7H8N2O2; and Pioglitazone MPO. The
hard objectives we use include Osimertinib MPO, Fexofenadine MPO, Ranolazine MPO,
Perindopril MPO, Amlodipine MPO, Ranolazine MPO , Sitagliptin MPO, Zaleplon MPO,
Valsartan SMARTS, Scaffold Hop and Decorator Hop. Some MPO tasks try to identify
molecules dissimilar to the titular molecule but with similar properties; other MPO tasks
try to identify molecules similar to the titular molecule but with “improved” druglikeness
properties. We didn’t include the benchmarks that measure the similarity to commercial drug
molecules and isomer benchmarks in hard tasks because we think they are less meaningful
for drug discovery purposes. We refer readers to the list of benchmarks in ref. 27 for a full
description of these objectives.
Biasing techniques for molecular generation
• Post hoc filtering is the approach where a CASP tool is used to filter unsynthesizable
molecules suggested by an unbiased generation. We evaluate this approach by calcu-
lating the fraction of molecules that would pass the ASKCOS filter and their objective
function values.
• Training set biasing is the approach of starting with a molecule databases that has a
higher fraction of synthesizable compounds as the training set for deep learning meth-
ods or the starting pool for genetic algorithms. In this paper, we use ChEMBL (68.3%
as tested) and MOSES (89.8% as tested) as representative datasets with lower and
higher synthesizabilities, respectively. This approach can be used in both unoptimized
generation and optimized generation.
• Heuristic biasing is the approach of modifying the main objective function to penalize
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the generation of unsynthesizable compounds. We apply a synthesizability function
multiplier, ranging from 0 to 1, to a pre-normalized objective function (also ranging
from 0 to 1). Specifically, we use a form of modified Gaussian and sigmoid function to
rescale the heuristic score x:
Modifier =

1 x < µ
e−
(x−µ)2
2σ x ≥ µ
Modifier = 1− 1
1 + ea(x−b)
We performed 30 iterations of Tree Parzen Estimator (TPE) Bayesian Optimization
to determine the hyper-parameters for each score. The hyper-parameters aimed to
maximize the fraction of synthesizable suggestions times the average of the objective
function for the top 10 molecules from graph genetic algorithm. We tested the biasing
effect of SA Score, SCScore, and length of SMILES string, but meaningful parameters
could not be obtained for the SMILES string heuristic. The multipliers we use are
shown in Figure S4. This approach can only be used in optimized generation.
– SA Score31 is a popular heuristic score for quantifying synthesizability. It com-
putes a score using a fragment-contribution approach, where rarer fragments (as
judged by their abundance in the PubChem database) are taken as an indication
of lower synthesizability.
– SCScore20 is a learned synthetic complexity score computed by as neural network
model trained on reaction data from the Reaxys database. It was designed with
synthesis planning in mind to operate on molecules resembling not just drug-like
products, but intermediates and simpler building blocks as well.
– SMILES length is a very simple heuristic that associates molecules with longer
SMILES strings as an indication of synthetic difficulty. The length of a SMILES
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string correlates closely with the number of heavy atoms in a molecule (i.e., larger
molecules are harder to synthesize), but is further increased by the presence of
formal charges, ring closures, and defined stereochemistry.
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Additional Results
Suitability of heuristic functions for estimating synthesizability
1
Figure S1: Illustration of the difficulty of applying heuristics to estimate synthesizability. Ribavirin (left) and its analogue
(right) are structurally very similar, but their syntheses would be substantially different due to the inherent reactivity of
ribose to favor substitution at the position leading to ribavirin. The SA Score and SCScore do not reflect that the righthand
compound is much harder to access.
2
Figure S2: The synthetic pathway found by ASKCOS for ribavirin (left of Figure S1). By explicitly planning synthetic
routes, ASKCOS easily distinguishes between the two compounds as it cannot identify a synthetic pathway for the righthand
compound.
3
Figure S3: The receiver operating characteristic (ROC) curve obtained when using heuristic estimates of synthetic complexity
for binary classification of molecules in the “All but GDB” compound set as synthesizable or unsynthesizable as perceived by
ASKCOS. The area under the curve (AUC) quantifies the visual trends observed in Figure 2c-e. On this compound set, the
SA Score outperforms the SMILES heuristic, which outperforms the SCScore. All three are better than randomly guessing.
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Full results of heuristics biasing in goal-directed generation
Figure S4: The scaled synthesizability multipliers used for heuristic biasing after optimizing shape parameters (µ and σ) (see
Methods).
5
Figure S5: Change of synthesizability and objective function with heuristic biasing. (a) Biasing with SA Score after training
on ChEMBL; (b) biasing with SCScore after training on ChEMBL; (c) biasing with SA Score after training on MOSES;
(d) biasing with SCScore after training on MOSES. Within each panel, each row represents one generative method; each
column represents one objective function. In each plot, the green solid line represents the change of fraction of synthesizable
compounds in the top-100, with the green dashed line as a reference for the synthesizability of the training set (ChEMBL
or MOSES). Red solid lines represent the change in the objective function value of the top synthesizable molecule, while the
dashed red line represents the change in objective function value of the top molecule, regardless of its synthesizability. Plots
without a solid red line indicates that no synthesizable structure was obtained in the top 100 molecules. All plots have a
dashed red line, though it might be occluded by the solid line.
6
Figure S6: The synthesizable fraction of top-100 candidates proposed during goal-directed optimization for “hard” optimiza-
tion tasks. (left) Without biasing; (middle) with heuristic biasing by SA Score; (right) with heuristic biasing by SCScore.
(top) using ChEMBL for initial training; (botom) using MOSES for initial training. For many tasks, ASKCOS is unable to
identify routes to a large fraction of generated molecules, particularly when using the Graph GA or SMILES GA methods.
Figure S7: The average objective function value of the top-10 synthesizable candidates, identified through post hoc filtering
of the top-100 candidates proposed during goal-directed optimization for “hard” optimization tasks. (left) Without biasing;
(middle) with heuristic biasing by SA Score; (right) with heuristic biasing by SCScore. (top) using ChEMBL for initial
training; (botom) using MOSES for initial training. White squares with a value of 0.00 indicates that fewer than 10 of the
top 100 molecules were identified as synthesizable by ASKCOS. The top row showing the Best from Dataset represents a
virtual screening approach.
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Figure S8: The synthesizable fraction of top-100 candidates proposed during goal-directed optimization for “trivial” opti-
mization tasks. (left) Without biasing; (middle) with heuristic biasing by SA Score; (right) with heuristic biasing by SCScore.
(top) using ChEMBL for initial training; (botom) using MOSES for initial training. Synthesizability is primarily an issue for
the Pioglitazone MPO task.
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Figure S9: The average objective function value of the top-10 synthesizable candidates, identified through post hoc filtering of
the top-100 candidates proposed during goal-directed optimization for “trivial” optimization tasks. (left) Without biasing;
(middle) with heuristic biasing by SA Score; (right) with heuristic biasing by SCScore. (top) using ChEMBL for initial
training; (botom) using MOSES for initial training. White squares with a value of 0.00 indicates that fewer than 10 of the
top 100 molecules were identified as synthesizable by ASKCOS. The top row showing the Best from Dataset represents a
virtual screening approach.
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Successful cases of heuristic biasing in goal-directed generation
10
(a) SMILES GA / Ranolazine MPO / ChEMBL
(b) Graph GA / Ranolazine MPO / ChEMBL
(c) SMILES GA / Perindopril MPO / ChEMBL
(d) Graph GA / Perindopril MPO / ChEMBL
Figure S10: Molecules proposed during goal-directed optimization where there are no synthesizable structures proposed in
the top 100 candidates in the absence of heuristic biasing. Each row represents a particular method, objective function,
and initial training set. From left to right, we draw the best (unsynthesizable) molecule, the best synthesizable molecule
after biasing with the SA Score, and the best synthesizable molecule after biasing with the SCScore. Many of the structures
proposed by the SMILES GA and Graph GA methods are nonsensical and clearly unsynthesizable, despite achieving a high
objective function value.
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(a) SMILES GA / Amlodipine MPO / ChEMBL
(b) Graph GA / Sitagliptin MPO / ChEMBL
(c) SMILES GA / Scaffold Hop / ChEMBL
(d) SMILES GA / Osimertinib MPO / MOSES
Figure S11: Molecules proposed during goal-directed optimization where there are no synthesizable structures proposed in
the top 100 candidates in the absence of heuristic biasing. Each row represents a particular method, objective function,
and initial training set. From left to right, we draw the best (unsynthesizable) molecule, the best synthesizable molecule
after biasing with the SA Score, and the best synthesizable molecule after biasing with the SCScore. Many of the structures
proposed by the SMILES GA and Graph GA methods are nonsensical and clearly unsynthesizable, despite achieving a high
objective function value.
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(a) Graph GA / Fexofenadine MPO / MOSES
(b) SMILES GA / Ranolazine MPO / MOSES
(c) Graph GA / Ranolazine MPO / MOSES
(d) SMILES GA / Decoration Hop / MOSES
Figure S12: Molecules proposed during goal-directed optimization where there are no synthesizable structures proposed in
the top 100 candidates in the absence of heuristic biasing. Each row represents a particular method, objective function, and
initial training set. From left to right, we draw the best (unsynthesizable) molecule, the best synthesizable molecule after
biasing with the SA Score, and the best synthesizable molecule after biasing with the SCScore.
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(a) SMILES LSTM / Sitagliptin MPO / ChEMBL
(b) SMILES LSTM / Ranolazine MPO / MOSES
(c) SMILES LSTM / Sitagliptin MPO / MOSES
(d) SMILES LSTM / Zaleplon MPO / MOSES
Figure S13: Molecules proposed during goal-directed optimization where the main objective function value of the top-1
synthesizable structure is improved by heuristic biasing. Each row represents a particular method, objective function, and
initial training set. From left to right, we draw the best (unsynthesizable) molecule, the best synthesizable molecule, the best
synthesizable molecule after biasing with the SA Score, and the best synthesizable molecule after biasing with the SCScore.
All cases shown here use the SMILES LSTM method.
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Agreement between ASKCOS results and synthesizability heuristics
Figure S14: Correlation between the length of the first synthetic pathway found by ASKCOS and expert scores assigned by
chemists in Sheridan et al..17 A length of 0 indicates that the molecule can be found in our database of readily-purchasable
compounds; a length of 11 indicates that no pathway was found with the fixed expansion settings (see Methods).
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Figure S15: Correlation between the length of the first synthetic pathway found by ASKCOS using all compound datasets
and the SA Score31 heuristic. A length of 0 indicates that the molecule can be found in our database of readily-purchasable
compounds; a length of 11 indicates that no pathway was found with the fixed expansion settings (see Methods).
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Figure S16: Correlation between the length of the first synthetic pathway found by ASKCOS using all compound datasets
and the SCScore20 heuristic A length of 0 indicates that the molecule can be found in our database of readily-purchasable
compounds; a length of 11 indicates that no pathway was found with the fixed expansion settings (see Methods).
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Figure S17: Correlation between the length of the first synthetic pathway found by ASKCOS using all compound datasets and
the SMILES length heuristic A length of 0 indicates that the molecule can be found in our database of readily-purchasable
compounds; a length of 11 indicates that no pathway was found with the fixed expansion settings (see Methods).
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Figure S18: Correlation between Sheridan et al.’s meanComplexity17 and the SA Score;31 each compound is colored by its
synthesizability according to ASKCOS.
Figure S19: Correlation between Sheridan et al.’s meanComplexity17 and the SCScore;20 each compound is colored by its
synthesizability according to ASKCOS.
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Figure S20: Correlation between Sheridan et al.’s meanComplexity17 and the SMILES string length; each compound is
colored by its synthesizability according to ASKCOS.
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